Use of transposase and Y adapters to fragment and tag DNA

US11535889B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11535889-B2
Application numberUS-201916295838-A
CountryUS
Kind codeB2
Filing dateMar 7, 2019
Priority dateMar 31, 2016
Publication dateDec 27, 2022
Grant dateDec 27, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein is an adapter comprising a population of first oligonucleotides, a second oligonucleotide and a third oligonucleotide, wherein the first oligonucleotides, the second oligonucleotide and the third oligonucleotide are hybridized together to produce a complex that comprises: (i) a first end comprising a transposase recognition sequence, (ii) a central single-stranded region of variable sequence and (iii) a second end comprising sequences that are non-complementary. A method, as well as a kit for practicing the method, are also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for tagmenting a sample, comprising: contacting a sample comprising double-stranded DNA with a transposase loaded with adapters; wherein the adapters comprise a population of first oligonucleotides, a second oligonucleotide and a third oligonucleotide, wherein the first oligonucleotides, the second oligonucleotide and the third oligonucleotide are hybridized together to produce a complex that comprises: (i) a first end comprising a transposase recognition sequence, (ii) a central single-stranded region of variable sequence and (iii) a second end comprising sequences that are non-complementary; and filling in and sealing the central single-stranded region of the adaptor using a polymerase and ligase, thereby producing a population of DNA fragments that are tagged at both ends by a Y adaptor each comprising the variable sequence of a first oligonucleotide on both strands. 2. The method of claim 1 , wherein the method is done by combining, in a single reaction vessel, the sample, the transposase loaded with the adaptors, the polymerase and the ligase. 3. The method of claim 1 , wherein the filling in is done by Sulfolobus DNA polymerase IV, at a temperature less than 50 degrees Celsius. 4. The method of claim 1 , wherein the method further comprises amplifying the population of DNA fragments using primers that target a non-complementary sequence of the Y adaptor. 5. The method of claim 4 , wherein the amplifying is done in solution. 6. The method of claim 4 , wherein the amplifying is done by bridge PCR. 7. The method of claim 1 , further comprising sequencing at least some of the tagged DNA fragments. 8. The method of claim 1 , wherein the variable sequence has a complexity of at least 1,000. 9. The method of claim 1 , wherein the first, second, and third oligonucleotides are formed by allowing self-annealing of a single oligonucleotide molecule of greater than 60 nucleotides, followed by cleavage of cleavable sites located between the first and third oligonucleotides and between the second and third oligonucleotide. 10. The method of claim 1 , wherein the transposase recognition sequence is a recognition sequence for a Vibhar transposase. 11. The method of claim 1 , wherein: a) the population of first oligonucleotides comprise a 5′ region, a 3′ region, and a region of variable sequence between the 5′ region and the 3′ region; b) the second oligonucleotide is complementary to and hybridizes with the 3′ region of the first oligonucleotides to form the transposase recognition sequence; and c) the third oligonucleotide comprises a 5′ end that is complementary to and is hybridized with the 3′ end of the 5′ region of the first oligonucleotide and comprises a 3′ tail that is non-complementary to the 5′ end of the 5′ region of the first oligonucleotide. 12. The method of claim 11 , wherein the 5′ end of the first oligonucleotide and the 3′ tail of the third oligonucleotide are in a single molecule and joined together by a cleavable region. 13. The method of claim 11 , wherein the 3′ tail of the third oligonucleotide comprises a modification rendering the 3′ end resistant to digestion by a 3′-5′ exonuclease activity.

Assignees

Inventors

Classifications

  • Methods for sequencing · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • C12Q1/6855Primary

    Ligating adaptors · CPC title

  • characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11535889B2 cover?
Described herein is an adapter comprising a population of first oligonucleotides, a second oligonucleotide and a third oligonucleotide, wherein the first oligonucleotides, the second oligonucleotide and the third oligonucleotide are hybridized together to produce a complex that comprises: (i) a first end comprising a transposase recognition sequence, (ii) a central single-stranded region of var…
Who is the assignee on this patent?
Agilent Technologies Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6855. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).